Next Generation-Targeted Amplicon Sequencing (NG-TAS): An optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA

This research was supported with funding from Cancer Research UK Cancer Research UK (C37096/A16673). MG has been supported by a Genentech research grant (CLL-010907) awarded to the Caldas Laboratory. MC has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement no. 660060